A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference50 articles.
1. Cancer statistics, 2014;R Siegel;CA: a cancer journal for clinicians,2014
2. Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer;H Ren;Molecular cancer therapeutics,2009
3. Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. Journal of controlled release: official journal of the;IY Kim;Controlled Release Society,2009
4. Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9;H Wang;Molecular cancer therapeutics,2006
5. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?;D Ferrigno;Lung cancer,2000
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice;eBioMedicine;2024-07
2. Graph Attention Networks for Drug Combination Discovery: Targeting Pancreatic Cancer Genes with RAIN Protocol;2024-02-28
3. RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions;Cancer Medicine;2024-01
4. Cancer therapy with iRGD as a tumor-penetrating peptide;Bulletin du Cancer;2023-12
5. Exploration of tumor penetrating peptide iRGD as a potential strategy to enhance tumor penetration of cancer nanotherapeutics;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3